Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity

被引:88
作者
Nasr, Samih H. [1 ]
D'Agati, Vivette D. [1 ]
Park, Hye-Ran [2 ]
Sterman, Paul L. [3 ]
Goyzueta, Juan D. [4 ]
Dressler, Robert M. [5 ]
Hazlett, Shawn M. [6 ]
Pursell, Robert N. [7 ]
Caputo, Christopher [8 ]
Markowitz, Glen S. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] Med Associates Drexel Hill Inc, Drexel Hill, PA USA
[3] St Peters Univ Hosp, New Brunswick, NJ USA
[4] Catskill Reg Med Ctr, Harris, NY USA
[5] Christian Care Hlth Serv, Dept Med, Newark, DE USA
[6] Lehigh Valley Hosp, Dept Med, Allentown, PA USA
[7] St Lukes Hosp, Dept Med, Bethlehem, PA USA
[8] Queens Nassau Nephrol Serv PLLC, Garden City, NY USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 3卷 / 03期
关键词
D O I
10.2215/CJN.04391007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Lupus nephritis is a classic immune complex glomerulonephritis. In contrast, antineutrophil cytoplasmic antibodies are associated with necrotizing and crescentic glomerulonephritis, in the absence of significant immune deposits. Antineutrophil cytoplasmic antibodies are detected by indirect immunofluorescence in 20% of patients with systemic lupus erythematosus. We report 10 cases of necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Design, setting, participants, & measurements: Ten patients with systemic lupus erythematosus, antineutrophil cytoplasmic antibody positivity, and renal biopsy findings of lupus nephritis and antineutrophil cytoplasmic antibody-associated glomerulonephritis were identified. The clinical features, pathologic findings, and outcomes are described. Results: The cohort consisted of eight women and two men with a mean age of 48.4 yr. Perinuclear antineutrophil cytoplasmic antibody was detected by indirect immunofluorescence in nine patients. Four of the nine patients and the single remaining patient were found to have myeloperoxidase-antineutrophil cytoplasmic antibodies by enzyme-linked immunosorbent assay. Clinical presentation included proteinuria, hematuria, and acute renal insufficiency, with mean creatinine of 7.1 mg/dl. All biopsies exhibited prominent necrosis and crescents with absent or rare subendothelial deposits and were interpreted as lupus nephritis and antineutrophil cytoplasmic antibody-associated glomerulonephritis. All patients received cyclophosphamide and prednisone. Three patients died of infectious complications. Among the remaining seven patients, five achieved a complete or near-complete remission, one had a remission with subsequent relapse, and one had no response to therapy. Conclusion: Antineutrophil cytoplasmic antibody-associated necrotizing and crescentic glomerulonephritis may occur superimposed on lupus nephritis. In patients with lupus nephritis and biopsy findings of prominent necrosis and crescent formation in the absence of significant endocapillary proliferation or subendothelial deposits, antineutrophil cytoplasmic antibody testing by enzyme-linked immunosorbent assay is recommended.
引用
收藏
页码:682 / 690
页数:9
相关论文
共 27 条
[1]   PAUCI-IMMUNE NECROTIZING LUPUS NEPHRITIS - REPORT OF 2 CASES [J].
AKHTAR, M ;
ALDALAAN, A ;
ELRAMAHI, KM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :320-325
[2]   Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins [J].
Arahata, H ;
Migita, K ;
Izumoto, H ;
Miyashita, T ;
Munakata, H ;
Nakamura, H ;
Tominaga, M ;
Origuchi, T ;
Kawabe, Y ;
Hida, A ;
Taguchi, T ;
Eguchi, K .
CLINICAL RHEUMATOLOGY, 1999, 18 (01) :77-81
[3]   Pauci-immune proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome [J].
Charney, DA ;
Nassar, G ;
Truong, L ;
Nadasdy, T .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1193-1206
[4]   Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis [J].
Chin, HJ ;
Ahn, C ;
Lim, CS ;
Chung, HK ;
Lee, JG ;
Song, YW ;
Lee, HS ;
Han, JS ;
Kim, S ;
Lee, JS .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (01) :57-63
[5]  
Choi HK, 2000, ARTHRITIS RHEUM, V43, P405, DOI 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO
[6]  
2-5
[7]  
FERRARIO F, 1992, CONTRIB NEPHROL, V99, P86
[8]   Hydralazine-induced lupus: Maintaining vigilance with increased use in patients with heart failure [J].
Finks, Shannon W. ;
Finks, A. Lloyd ;
Self, Timothy H. .
SOUTHERN MEDICAL JOURNAL, 2006, 99 (01) :18-22
[9]  
Galeazzi M, 1998, CLIN EXP RHEUMATOL, V16, P541
[10]   ANCA-positive vasculitis induced by thioridazine: confirmed by rechallenge [J].
Greenfield, JR ;
McGrath, M ;
Kossard, S ;
Charlesworth, JA ;
Campbell, LV .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (06) :1265-1267